Tamoxifen in breast cancer survivors with COVID 19: stop or go?

Thumbnail

View/Open

Access

info:eu-repo/semantics/closedAccess

Date

2021

Author

Karaçin, Cengiz
Karaçin, Pınar
Ergün, Yakup

Metadata

Show full item record

Citation

Karacin, C., Karacin, P., & Ergun, Y. (2021). Tamoxifen in breast cancer survivors with COVID 19: stop or go?. Medical oncology (Northwood, London, England), 38(4), 42. https://doi.org/10.1007/s12032-021-01492-z

Abstract

The COVID 19 pandemic threatens human health in many ways. Although vaccines that have completed phase 3 trials are being used today, it is estimated that the risk of infection will continue for a while

Source

Medical Oncology

Volume

38

Issue

4

URI

https://doi.org/10.1007/s12032-021-01492-z
https://hdl.handle.net/11436/6279

Collections